Selective

Selective Insurance Schedules Earnings Release and Conference Call to Announce Third Quarter 2023 Results

Retrieved on: 
Monday, October 2, 2023

BRANCHVILLE, N.J., Oct. 2, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) will announce its third quarter financial results on Wednesday, November 1, 2023, after market close.

Key Points: 
  • BRANCHVILLE, N.J., Oct. 2, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) will announce its third quarter financial results on Wednesday, November 1, 2023, after market close.
  • The press release and financial supplement will be available on the Investors page of Selective's website.
  • A conference call to discuss the results will be held on Thursday, November 2, 2023, at 11:00 AM ET.
  • A replay will be available on the website from November 2 to December 1, 2023.

Selective to Present at the 2023 Keefe, Bruyette & Woods Insurance Conference

Retrieved on: 
Tuesday, August 29, 2023

Key Points: 
  • BRANCHVILLE, N.J., Aug. 29, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) announced today that executives John J. Marchioni, Chairman, President and Chief Executive Officer, and Mark A. Wilcox, Executive Vice President, Chief Financial Officer, will present at the 2023 Keefe, Bruyette & Woods Insurance Conference on Thursday, September 7, 2023 at 12:50 p.m.
  • ET.
  • Investors can listen live to Selective's presentation or access a recording by visiting the Investors page of www.Selective.com through October 6, 2023.

Key Competitor Analysis and Market Shares in the Selective Laser Sintering Equipment Industry - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 16, 2023

The "Selective Laser Sintering Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Selective Laser Sintering Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The study examines various applications of Selective Laser Sintering Equipment, including tooling, heavy equipment & machinery, and robotics, and presents independent analyses of their annual sales.
  • Additionally, the report highlights the presence of strong, active, niche, or trivial market players in each region, offering valuable insights for investors and industry stakeholders.
  • The U.S. Market is Estimated at $203.1 Million, While China is Forecast to Grow at 19% CAGR
    The Selective Laser Sintering Equipment market in the U.S. is estimated at US$203.1 Million in the year 2022.

Foghorn Therapeutics Provides Second Quarter 2023 Financial and Corporate Update

Retrieved on: 
Friday, August 4, 2023

CAMBRIDGE, Mass., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today provided a financial and corporate update in conjunction with the Company’s 10-Q filing for the quarter ended June 30, 2023. With an initial focus in oncology, Foghorn’s Gene Traffic Control® Platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

Key Points: 
  • “Foghorn made important progress across both our clinical and preclinical pipeline in the second quarter.
  • We are on track to initiate dosing in a combination study of FHD-286 in AML in the third quarter.
  • On June 28, 2023, Foghorn announced data from the Phase 1 dose escalation safety study of FHD-286 in metastatic uveal melanoma (mUM).
  • As of June 30, 2023, the Company had $284.3 million in cash, cash equivalents and marketable securities, which provides a cash runway into the second half of 2025.

Selective Insurance Group, Inc. Announces Preliminary Second Quarter 2023 Results, Including Catastrophe Loss Estimates

Retrieved on: 
Monday, July 24, 2023

BRANCHVILLE, N.J., July 24, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) announced preliminary second quarter 2023 results and pre-tax net catastrophe loss estimates today.

Key Points: 
  • BRANCHVILLE, N.J., July 24, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) announced preliminary second quarter 2023 results and pre-tax net catastrophe loss estimates today.
  • The Company expects its second quarter combined ratio to be 100.2%, including catastrophe losses of 10.6 points and net prior year favorable casualty reserve development of 0.4 points.
  • We expect to release our second quarter 2023 results after market close on August 2, 2023.
  • Any changes in our preliminary estimates, including changes to pre-tax net catastrophe losses, will be reflected in these results.

Selective Insurance Earns Fourth Consecutive Great Place To Work Certification™

Retrieved on: 
Tuesday, July 18, 2023

BRANCHVILLE, N.J., July 18, 2023 /PRNewswire/ -- Selective Insurance, a leading business, home, and auto insurer, is proud to be Certified™ by Great Place To Work® for the fourth consecutive year.

Key Points: 
  • BRANCHVILLE, N.J., July 18, 2023 /PRNewswire/ -- Selective Insurance, a leading business, home, and auto insurer, is proud to be Certified™ by Great Place To Work® for the fourth consecutive year.
  • "We are delighted they continue to say Selective is a Great Place to Work.
  • "Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," said Sarah Lewis-Kulin, Vice President of Global Recognition at Great Place To Work.
  • According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified great workplace.

Verisk Names Samantha Vaughan Chief Privacy Officer

Retrieved on: 
Wednesday, July 12, 2023

JERSEY CITY, N.J., July 12, 2023 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today announced that Samantha Vaughan has been named chief privacy officer, effective immediately.

Key Points: 
  • JERSEY CITY, N.J., July 12, 2023 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today announced that Samantha Vaughan has been named chief privacy officer, effective immediately.
  • “We’re excited to welcome Samantha to Verisk,” said Kathy Card Beckles, chief legal officer and corporate secretary, Verisk.
  • “Data privacy has always been core to Verisk and central to our work with the global insurance industry.
  • Prior to Dell, she was the senior vice president, Corporate Ethics & Compliance and chief privacy officer for Wyndham Hotels & Resorts.

Selective Insurance Schedules Earnings Release and Conference Call to Announce Second Quarter 2023 Results

Retrieved on: 
Thursday, July 6, 2023

BRANCHVILLE, N.J., July 6, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) will announce its second quarter financial results on Wednesday, August 2, 2023, after market close.

Key Points: 
  • BRANCHVILLE, N.J., July 6, 2023 /PRNewswire/ -- Selective Insurance Group, Inc. (Nasdaq: SIGI) will announce its second quarter financial results on Wednesday, August 2, 2023, after market close.
  • The press release and financial supplement will be available on the Investors page of Selective's website.
  • A conference call to discuss the results will be held on Thursday, August 3, 2023, at 11:00 AM ET.
  • A replay will be available on the website from August 3 to September 1, 2023.

Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting

Retrieved on: 
Wednesday, June 14, 2023

Proof of concept for this platform has been achieved with clinical data from CUE-101, the company’s lead candidate.

Key Points: 
  • Proof of concept for this platform has been achieved with clinical data from CUE-101, the company’s lead candidate.
  • Additionally, Dr. Quayle will discuss the modularity of the Immuno-STAT platform, which has enabled rapid generation of additional Immuno-STAT candidates targeting other tumor antigens, such as mutated KRAS or Wilms’ Tumor 1 (WT1).
  • This includes Cue Biopharma’s second CUE-100 series candidate, CUE-102, that is being evaluated in a Phase 1 trial for the treatment of WT1 positive malignancies.
  • Taken together, the clinical de-risking achieved with CUE-101 supports broad applications of the Immuno-STAT platform to target diverse cancers.

Selective Insurance's Construction Risk Report Reveals Trends and Risks Facing General Contractors

Retrieved on: 
Tuesday, May 9, 2023

BRANCHVILLE, N.J., May 9, 2023 /PRNewswire/ -- Selective Insurance , a leading business insurance carrier with specialized expertise in the construction industry, today released a report on general contractors, risk, and insurance.

Key Points: 
  • BRANCHVILLE, N.J., May 9, 2023 /PRNewswire/ -- Selective Insurance , a leading business insurance carrier with specialized expertise in the construction industry, today released a report on general contractors, risk, and insurance.
  • Selective's General Contractors Risk Report presents data and observations for the various risks general contractors often experience, along with construction industry forecasts and business and safety management implications.
  • The General Contractors Risk Report highlights the three significant operational risks faced by general contractors:
    Inflation: Higher material and commodity prices increased the need for protection against property damage during construction.
  • The General Contractors Risk Report is one of Selective's many resources available to help general contractors understand and address risks facing their business.